You searched for viral vector - Page 18 of 53

News and Trends 28 Sep 2017

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Abivax’s HIV cure candidate, ABX464, caused a significant drop in the viral reservoir over an extended period during a Phase IIa study. Abivax targets the immune system to cure viral…

September 28, 2017 - 2 minutesmins - By Alex Dale

News and Trends 3 Jul 2019

EU Approves Two-Drug Pill as First-Line Treatment for HIV

The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as a first-line treatment for HIV, potentially causing fewer long-term side effects than current three-drug antiretroviral…

July 3, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 23 Nov 2022

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

…to all antibody therapies “For our studies, we mixed non-propagating viral particles carrying the spike protein of selected viral variants with different dilutions of the antibodies to be tested and…

November 23, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 21 Jul 2022

Vicebio exits stealth to work on next generation RSV vaccine

…stabilizing viral glycoproteins in “prefusion”conformation, to deliver protective and ready-to-use fully liquid vaccines. The technology is a protein tag that effectively stabilizes a wide range of complex viral proteins. It…

July 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 16 Aug 2022

Pneumagen embarks on phase 2 proof of concept influenza study

Biotech company Pneumagen says the first person has been dosed in its phase 2 controlled human infection challenge study. Its product, Neumifil, is an intranasal, broad-spectrum antiviral treatment to prevent…

August 16, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 10 Jun 2019

The 10 Biotech Companies in London to Keep an Eye on in 2019

…in 2018, the company is now valued at over €1B. Quite impressive given that it was only founded in 2014. Founded in 2011, ReViral aims to develop the first antiviral…

June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Dec 2022

Watch: Atriva Therapeutics at BIO-Europe

…The clinical-stage biopharmaceutical company is pioneering the development of host-targeting antiviral therapies, making development of viral resistance unlikely, and thereby significantly contributing to pandemic preparedness. The Atriva lead product zapnometinib…

December 19, 2022 - 1 minutemin - By Jim Cornall

In Depth 30 Oct 2023

The ongoing search for an HIV cure: can CRISPR crack the code?

…still no effective cure for it. The only option patients have is antiretroviral therapy, which, although it represents a major milestone in HIV treatment and has saved countless lives, it…

October 30, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 1 Dec 2016

It’s World AIDS Day, is Biotech close to an HIV Cure?

…for this devastating disease is antiretroviral therapy, which can stop the progression but does not eliminate the virus. Thus, biopharma is putting plenty of efforts into developing a cure, vaccines,…

December 1, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Jun 2018

People with Innate Resistance to HIV Could Provide a Functional HIV Cure

…builds a strong response to the HIV virus. Comprising less than 0.5% of all HIV-infected people, HIV controllers do not need antiretroviral therapy to keep AIDS symptoms at bay. …

June 8, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 24 Nov 2022

FDA gives IND approval for Ascletis Covid drug

…food effect study. The objective of phase I trial is to find the right dose to move into a pivotal phase II/III in Covid-19 patients. In antiviral cellular assays with…

November 24, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…simply because the company’s primary scientific approach involves the use of adeno-associated virus (AAV) vectors. These vectors are engineered viruses that deliver functional copies of genes into the patient’s cells….

August 22, 2024 - 9 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

EU Approves Two-Drug Pill as First-Line Treatment for HIV

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

Vicebio exits stealth to work on next generation RSV vaccine

Pneumagen embarks on phase 2 proof of concept influenza study

The 10 Biotech Companies in London to Keep an Eye on in 2019

Watch: Atriva Therapeutics at BIO-Europe

The ongoing search for an HIV cure: can CRISPR crack the code?

It’s World AIDS Day, is Biotech close to an HIV Cure?

People with Innate Resistance to HIV Could Provide a Functional HIV Cure

FDA gives IND approval for Ascletis Covid drug

Seven companies transforming the biotech industry in Italy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!